Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

129.63
Delayed Data
As of 3:59pm ET
 +0.46 / +0.36%
Today’s Change
110.56
Today|||52-Week Range
193.45
-32.04%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
AssetsCash1.2B1.0B710.2M597.6M
 
 
 
 
 
Short Term Investment Cash-158.8M-153.2M-299.9M-112.6M
 
 
 
 
 
Cash & Short Term Investments1.5B1.4B1.0B1.2B
 
 
 
 
 
 
ReceivablesReceivables512.3M532.8M586.2M609.3M
 
 
 
 
 
 
InventoriesInventories236.5M289.9M294.0M329.8M
 
 
 
 
 
 
Current AssetsOther Current Assets272.9M217.6M219.7M242.0M
 
 
 
 
 
Current Assets2.5B2.4B2.1B2.4B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross--873.2M----
 
 
Depreciation---176.1M----
 
 
Intangible Assets9.8B9.8B9.7B9.6B
 
 
 
 
 
Other Assets10.0B10.0B9.9B9.8B
 
 
 
 
 
Total Assets13.2B13.1B12.8B13.0B
 
 
 
 
 
 
LiabilitiesAccounts Payable47.0M57.4M42.9M29.0M
 
 
 
 
 
Short Term Debt175.0M175.0M35.4M79.1M
 
 
 
 
 
Accrued Expenses358.0M276.1M359.1M407.3M
 
 
 
 
 
Other Current Liabilities412.3M370.7M525.4M550.3M
 
 
 
 
 
Other Liabilities766.9M718.3M603.6M658.5M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt3.3B3.3B3.2B3.2B
 
 
 
 
 
Deferred Taxes-417.3M-529.0M-535.9M-570.1M
 
 
 
 
 
Other Liabilities232.3M224.7M280.8M320.8M
 
 
 
 
 
Total Liabilities4.9B4.9B4.7B4.8B
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity8.3B8.3B8.1B8.2B
 
 
 
 
 
Total Shareholder Equity8.3B8.3B8.1B8.2B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding226.0M225.6M224.2M224.2M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.